Hepcidin is a peptide hormone that regulates iron homeostasis and acts as an antimicrobial peptide. It is expressed and secreted by a variety of cell types in response to iron loading and inflammation. Hepcidin mediates iron homeostasis by binding to the iron exporter ferroportin, inducing its internalization and degradation via activation of the protein kinase Jak2 and the subsequent phosphorylation of ferroportin. Here we have shown that hepcidin-activated Jak2 also phosphorylates the transcription factor Stat3, resulting in a transcriptional response. Hepcidin treatment of ferroportin-expressing mouse macrophages showed changes in mRNA expression levels of a wide variety of genes. The changes in transcript levels for half of these genes were a direct effect of hepcidin, as shown by cycloheximide insensitivity, and dependent on the presence of Stat3. Hepcidin-mediated transcriptional changes modulated LPS-induced transcription in both cultured macrophages and in vivo mouse models, as demonstrated by suppression of IL-6 and TNF-α transcript and secreted protein. Hepcidin-mediated transcription in mice also suppressed toxicity and morbidity due to single doses of LPS, poly(I:C), and turpentine, which is used to model chronic inflammatory disease. Most notably, we demonstrated that hepcidin pretreatment protected mice from a lethal dose of LPS and that hepcidin-knockout mice could be rescued from LPS toxicity by injection of hepcidin. The results of our study suggest a new function for hepcidin in modulating acute inflammatory responses.
Ivana De Domenico, Tian Y. Zhang, Curry L. Koening, Ryan W. Branch, Nyall London, Eric Lo, Raymond A. Daynes, James P. Kushner, Dean Li, Diane M. Ward, Jerry Kaplan
Title and authors | Publication | Year |
---|---|---|
Emerging Therapeutic Targets of Sepsis-Associated Acute Kidney Injury
S Swaminathan, MH Rosner, MD Okusa |
Seminars in Nephrology | 2015 |
Iron homeostasis in host defence and inflammation
T Ganz, E Nemeth |
Nature Reviews Immunology | 2015 |
Hepcidin and Host Defense against Infectious Diseases
K Michels, E Nemeth, T Ganz, B Mehrad, JB Bliska |
PLoS pathogens | 2015 |
Iron Deficiency Impairs Intra-Hepatic Lymphocyte Mediated Immune Response
E Bonaccorsi-Riani, R Danger, JJ Lozano, M Martinez-Picola, E Kodela, R Mas-Malavila, M Bruguera, HL Collins, RC Hider, M Martinez-Llordella, A Sanchez-Fueyo, B Ryffel |
PloS one | 2015 |
Hepcidin Mitigates Renal Ischemia-Reperfusion Injury by Modulating Systemic Iron Homeostasis
Y Scindia, P Dey, A Thirunagari, H Liping, DL Rosin, M Floris, MD Okusa, S Swaminathan |
Journal of the American Society of Nephrology : JASN | 2015 |
Hepcidin-ferroportin axis controls toll-like receptor 4 dependent macrophage inflammatory responses in human atherosclerotic plaques
A Habib, R Polavarapu, V Karmali, L Guo, RV Dam, Q Cheng, H Akahori, O Saeed, M Nakano, K Pachura, CC Hong, E Shin, F Kolodgie, R Virmani, AV Finn |
Atherosclerosis | 2015 |
Reducing iron accumulation: A potential approach for the prevention and treatment of postmenopausal osteoporosis (Review)
B Chen, GF Li, Y Shen, X Huang, YJ Xu |
Experimental and therapeutic medicine | 2015 |
Lipopolysaccharide exacerbates infarct size and results in worsened post-stroke behavioral outcomes
Danielle N Doll, Elizabeth B Engler-Chiurazzi, Sara E Lewis, Heng Hu, Ashley E Kerr, Xuefang Ren, James W Simpkins |
Behavioral and Brain Functions | 2015 |
Ironing out Ferroportin
H Drakesmith, E Nemeth, T Ganz |
Cell Metabolism | 2015 |
Serum Hepcidin Predicts Uremic Accelerated Atherosclerosis in Chronic Hemodialysis Patients with Diabetic Nephropathy
W Wang, XD Zhang, SX Wang, H Li, SJ Feng, LL Su |
Chinese Medical Journal | 2015 |